These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 21364364

  • 1. A review of cases of neuromyelitis optica.
    Bomprezzi R, Postevka E, Campagnolo D, Vollmer TL.
    Neurologist; 2011 Mar; 17(2):98-104. PubMed ID: 21364364
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of rituximab on relapse rate and disability in neuromyelitis optica.
    Bedi GS, Brown AD, Delgado SR, Usmani N, Lam BL, Sheremata WA.
    Mult Scler; 2011 Oct; 17(10):1225-30. PubMed ID: 21622594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success.
    Greenberg BM, Graves D, Remington G, Hardeman P, Mann M, Karandikar N, Stuve O, Monson N, Frohman E.
    Mult Scler; 2012 Jul; 18(7):1022-6. PubMed ID: 22261118
    [Abstract] [Full Text] [Related]

  • 6. Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
    Ringelstein M, Harmel J, Distelmaier F, Ingwersen J, Menge T, Hellwig K, Kieseier B, Mayatepek E, Hartung HP, Kuempfel T, Aktas O.
    Mult Scler; 2013 Oct; 19(11):1544-7. PubMed ID: 23886825
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
    Weinstock-Guttman B, Miller C, Yeh E, Stosic M, Umhauer M, Batra N, Munschauer F, Zivadinov R, Ramanathan M.
    Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.
    Pellkofer HL, Krumbholz M, Berthele A, Hemmer B, Gerdes LA, Havla J, Bittner R, Canis M, Meinl E, Hohlfeld R, Kuempfel T.
    Neurology; 2011 Apr 12; 76(15):1310-5. PubMed ID: 21482945
    [Abstract] [Full Text] [Related]

  • 11. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.
    Ringelstein M, Ayzenberg I, Harmel J, Lauenstein AS, Lensch E, Stögbauer F, Hellwig K, Ellrichmann G, Stettner M, Chan A, Hartung HP, Kieseier B, Gold R, Aktas O, Kleiter I.
    JAMA Neurol; 2015 Jul 12; 72(7):756-63. PubMed ID: 25985228
    [Abstract] [Full Text] [Related]

  • 12. Rituximab use in pediatric central demyelinating disease.
    Beres SJ, Graves J, Waubant E.
    Pediatr Neurol; 2014 Jul 12; 51(1):114-8. PubMed ID: 24768216
    [Abstract] [Full Text] [Related]

  • 13. [Neuromyelitis optica].
    Kvistad SA, Wergeland S, Torkildsen Ø, Myhr KM, Vedeler CA.
    Tidsskr Nor Laegeforen; 2013 Oct 15; 133(19):2057-61. PubMed ID: 24129537
    [Abstract] [Full Text] [Related]

  • 14. Neuromyelitis optica.
    Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG.
    Curr Opin Neurol; 2007 Jun 15; 20(3):255-60. PubMed ID: 17495617
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Brain abnormalities in neuromyelitis optica.
    Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG.
    Arch Neurol; 2006 Mar 15; 63(3):390-6. PubMed ID: 16533966
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.
    Min JH, Waters P, Vincent A, Lee S, Y Shin H, H Lee K, Kim BJ.
    Acta Neurol Scand; 2012 Oct 15; 126(4):287-91. PubMed ID: 22309305
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of neuromyelitis optica].
    Nomura K.
    Nihon Rinsho; 2013 May 15; 71(5):829-38. PubMed ID: 23777090
    [Abstract] [Full Text] [Related]

  • 20. A Case Report on Juvenile Neuromyelitis Optica: Early Onset, Long Remission Period, and Atypical Treatment Response.
    Elpers C, Gross CC, Fiedler B, Meuth SG, Kurlemann G.
    Neuropediatrics; 2015 Aug 15; 46(4):292-5. PubMed ID: 26058738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.